Axsome Therapeutics (AXSM) EBIT (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162.53% |
| Dec 31, 2025 | 319.75% |
| Sep 30, 2025 | -25.59% |
| Jun 30, 2025 | 35.57% |
| Mar 31, 2025 | 21.53% |
| Dec 31, 2024 | -15.96% |
| Sep 30, 2024 | 19.76% |
| Jun 30, 2024 | -16.01% |
| Mar 31, 2024 | 31.54% |
| Dec 31, 2023 | -58.20% |
| Sep 30, 2023 | 4.51% |
| Jun 30, 2023 | -920.66% |
| Mar 31, 2023 | 89.36% |
| Dec 31, 2022 | -41.28% |
| Sep 30, 2022 | -8.25% |
| Jun 30, 2022 | -2.33% |
| Mar 31, 2022 | -17.42% |
| Dec 31, 2021 | 2.39% |
| Sep 30, 2021 | -8.30% |
| Jun 30, 2021 | -10.79% |
| Mar 31, 2021 | -0.36% |
| Dec 31, 2020 | -31.32% |
| Sep 30, 2020 | -18.83% |
| Jun 30, 2020 | 45.28% |
| Mar 31, 2020 | -33.01% |
| Dec 31, 2019 | -28.93% |
| Sep 30, 2019 | -40.89% |
| Jun 30, 2019 | -29.04% |
| Mar 31, 2019 | -210.28% |
| Dec 31, 2018 | 214.64% |
| Sep 30, 2018 | -3.18% |
| Jun 30, 2018 | -11.54% |
| Mar 31, 2018 | -211.16% |
| Dec 31, 2017 | 2.33% |
| Sep 30, 2017 | -6.72% |
| Jun 30, 2017 | -12.01% |
| Mar 31, 2017 | 0.61% |
| Dec 31, 2016 | 5.80% |
| Sep 30, 2016 | 5.57% |
| Jun 30, 2016 | 16.05% |
| Mar 31, 2016 | 86.49% |
| Dec 31, 2015 | 55.87% |
| Sep 30, 2015 | -2.93% |
| Jun 30, 2015 | 7.85% |